Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Jun 9;16(12):1700–1706. doi: 10.1016/j.bbmt.2010.06.003

Table 2.

Patient, Disease, and Transplant Characteristics of Caucasian Patients with MDS or CML

MDS CML
Number of patients 765 1644

Age (years) median (range) 48.3 (0.9 – 78.9) 37.1 (0.7 – 69.7)

Patient-donor gender (No. of pts. [%]):
 Female-Female 150 (20) 307 (19)
 Female-Male 168 (22) 343 (21)
 Male-Female 186 (24) 401 (24)
 Male-Male 253 (33) 588 (36)
 Unknown 8 (1) 5 (<1)

Conditioning Regimen (No. of pts [%])1:
 High intensity 706 (92) 1626 (99)

 Reduced-intensity 59 (8) 18 (1)

Donor (No. of pts. [%]):
 HLA-identical sibling 346 (45) 731 (44)
 HLA-matched unrelated donor 349 (46) 676 (41)
 Non-sibling relative or mismatched sibling 62 (8) 235 (14)
 Autologous* 8 (1) 2 (<1)

Stem Cell Source (No. of pts. [%]):
 Bone marrow 403 (53) 1522 (93)
 Peripheral blood 356 (47) 117 (7)
 Bone marrow+peripheral blood 4 (<1) 2 (<1)
 Cord blood 2 (<1) 3 (<1)

Years transplanted (No. of pts. [%]):
 1969–1985 26 (3) 228 (14)
 1986–1990 75 (10) 391 (24)
 1991–1995 162 (21) 490 (30)
 1996–2000 173 (23) 393 (24)
 2001–2005 224 (29) 113 (7)
 2006-present 105 (14) 29 (2)
1

High intensity: CY/TBI; tBU/CY; FLU/BU [3134];

Reduced intensity: FLU/TBI [35]

*

Not further considered in the outcome analysis